Sameer Alharthi
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Protein Tyrosine Phosphatases 3
- Co-authors
- Abdel‐Moneim M. Osman (12 shared papers)Lateef M. Khan (12 shared papers)Mohamed F. Elshal (5 shared papers)Omar I. Saadah (11 shared papers)Huda Mohammed Alkreathy (10 shared papers)Wafaa S. Ramadan (5 shared papers)Ahmed S. Ali (4 shared papers)Mohamed Alaama (2 shared papers)
- Journals
- Saudi Pharmaceutical Journal (4 papers)Cancer Cell International (4 papers)Stem Cells (3 papers)Biomedicines (1 paper)Pharmaceuticals (1 paper)
- Partner nations
- Saudi ArabiaEgyptUnited Kingdom
In The Last Decade
Sameer Alharthi
40 papers receiving 751 citations
Peers
Comparison fields: 5 of 91
- Toxicology 99
- Geriatrics and Gerontology 83
- Applied Microbiology and Biotechnology 34
- Ophthalmology 46
- Cardiology and Cardiovascular Medicine 86
Countries citing papers authored by Sameer Alharthi
This map shows the geographic impact of Sameer Alharthi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Alharthi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Alharthi more than expected).
Fields of papers citing papers by Sameer Alharthi
This network shows the impact of papers produced by Sameer Alharthi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Alharthi. The network helps show where Sameer Alharthi may publish in the future.
Co-authors
The 25 scholars most cited alongside Sameer Alharthi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 77 | |
| 2 | 2014 | 64 | |
| 3 | 2013 | 57 | |
| 4 | 2017 | 54 | |
| 5 | 2015 | 52 | |
| 6 | 2011 | 51 | |
| 7 | 2012 | 42 | |
| 8 | 2015 | 39 | |
| 9 | 2017 | 35 | |
| 10 | 2018 | 30 | |
| 11 | 2010 | 25 | |
| 12 | 2012 | 24 | |
| 13 | 2015 | 19 | |
| 14 | 2012 | 19 | |
| 15 | 2012 | 18 | |
| 16 | 2015 | 16 | |
| 17 | 2017 | 16 | |
| 18 | 2013 | 15 | |
| 19 | 2015 | 11 | |
| 20 | Serum Interleukin-33 level in Saudi children with inflammatory bowel disease. | 2015 | 11 |
About Sameer Alharthi
Sameer Alharthi is a scholar working on Molecular Biology, Physiology, Toxicology, Surgery and Cardiology and Cardiovascular Medicine, having authored 41 papers that have together received 766 indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (3 papers), Protein Tyrosine Phosphatases (3 papers), Inflammatory Bowel Disease (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Celiac Disease Research and Management (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Toxicology (99 citations), Geriatrics and Gerontology (83 citations), Applied Microbiology and Biotechnology (34 citations), Ophthalmology (46 citations) and Cardiology and Cardiovascular Medicine (86 citations). Sameer Alharthi has collaborated with scholars based in Saudi Arabia, Egypt and United Kingdom. Frequent co-authors include Abdel‐Moneim M. Osman, Lateef M. Khan, Mohamed F. Elshal, Omar I. Saadah, Huda Mohammed Alkreathy, Wafaa S. Ramadan, Ahmed S. Ali, Mohamed Alaama, Robin Plevin and Laurence Cadalbert. Their work appears in journals such as Saudi Pharmaceutical Journal, Cancer Cell International, Stem Cells, Biomedicines and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.